Literature DB >> 7823967

Carbohydrate heterogeneity of human myeloma proteins of the IgA1 and IgA2 subclasses.

T Endo1, J Mestecky, R Kulhavy, A Kobata.   

Abstract

Comparative studies of the N-linked carbohydrate chains of human myeloma proteins of the IgA1 and IgA2 subclasses were performed. The N-linked carbohydrate chains were released by hydrazinolysis from the polypeptide backbone, converted to radioactive oligosaccharides by sodium borotritide reduction after N-acetylation and separated into one neutral and two acidic fractions by paper electrophoresis. The acidic oligosaccharides were completely converted to neutral oligosaccharides by sialidase treatment, indicating that they were sialyl derivatives. The neutral and sialidase-treated acidic oligosaccharides were further fractionated by Bio-Gel P-4 column chromatography. Structural studies of each oligosaccharide by sequential exoglycosidase digestion and methylation analysis revealed that human myeloma IgA proteins contained significant amounts of biantennary complex-type carbohydrate chains in addition to a small amount of the high mannose-type. The results indicated that the oligosaccharide structures of human IgA1 and IgA2 display a high degree of heterogeneity not only in the number of carbohydrate chains, but also in their composition.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7823967     DOI: 10.1016/0161-5890(94)90157-0

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  10 in total

Review 1.  Progress in molecular and genetic studies of IgA nephropathy.

Authors:  J Novak; B A Julian; M Tomana; J Mesteck
Journal:  J Clin Immunol       Date:  2001-09       Impact factor: 8.317

2.  Differences in N-glycan structures found on recombinant IgA1 and IgA2 produced in murine myeloma and CHO cell lines.

Authors:  Esther M Yoo; Li J Yu; Letitia A Wims; David Goldberg; Sherie L Morrison
Journal:  MAbs       Date:  2010-05-17       Impact factor: 5.857

3.  Multiple Reaction Monitoring for the Quantitation of Serum Protein Glycosylation Profiles: Application to Ovarian Cancer.

Authors:  Suzanne Miyamoto; Carol D Stroble; Sandra Taylor; Qiuting Hong; Carlito B Lebrilla; Gary S Leiserowitz; Kyoungmi Kim; L Renee Ruhaak
Journal:  J Proteome Res       Date:  2017-12-19       Impact factor: 4.466

4.  Evidence for a site-specific fucosylation of N-linked oligosaccharide of immunoglobulin A1 from normal human serum.

Authors:  A Tanaka; H Iwase; Y Hiki; T Kokubo; I Ishii-Karakasa; K Toma; Y Kobayashi; K Hotta
Journal:  Glycoconj J       Date:  1998-10       Impact factor: 2.916

5.  New detection method after cellulose acetate membrane isoelectric focusing: activity staining for lactate dehydrogenase, detection for sugar chains using lectin and simple western blotting.

Authors:  S Iijima; M Kimura; K Shiba
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

6.  Cleavage of the human immunoglobulin A1 (IgA1) hinge region by IgA1 proteases requires structures in the Fc region of IgA.

Authors:  Koteswara R Chintalacharuvu; Philip D Chuang; Ashley Dragoman; Christine Z Fernandez; Jiazhou Qiu; Andrew G Plaut; K Ryan Trinh; Françoise A Gala; Sherie L Morrison
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

7.  Simultaneous analysis of serum immunoglobulins in patients with M protein using cellulose acetate membrane isoelectric focusing.

Authors:  S Iijima; K Shiba; Y Kurihara; S Kamei; S Kimura; M Kimura; Y Fukumura; I Kobayashi
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

8.  Analysis of IgA1 N-glycosylation and its contribution to FcalphaRI binding.

Authors:  Michelle M Gomes; Stephanie B Wall; Kazuo Takahashi; Jan Novak; Matthew B Renfrow; Andrew B Herr
Journal:  Biochemistry       Date:  2008-10-01       Impact factor: 3.162

9.  Improved in vivo anti-tumor effects of IgA-Her2 antibodies through half-life extension and serum exposure enhancement by FcRn targeting.

Authors:  Saskia Meyer; Maaike Nederend; J H Marco Jansen; Karli R Reiding; Shamir R Jacobino; Jan Meeldijk; Niels Bovenschen; Manfred Wuhrer; Thomas Valerius; Ruud Ubink; Peter Boross; Gerard Rouwendal; Jeanette H W Leusen
Journal:  MAbs       Date:  2015-10-14       Impact factor: 5.857

Review 10.  Specific antibody activity, glycan heterogeneity and polyreactivity contribute to the protective activity of S-IgA at mucosal surfaces.

Authors:  Jiri Mestecky; Michael W Russell
Journal:  Immunol Lett       Date:  2009-04-05       Impact factor: 3.685

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.